Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-02-12 @ 3:40 AM
Study NCT ID:
NCT02921269
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2016-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cervical Adenocarcinoma | View |
| None | Cervical Adenosquamous Carcinoma | View |
| None | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | View |
| None | Recurrent Cervical Carcinoma | View |
| None | Stage IV Cervical Cancer AJCC v6 and v7 | View |
| None | Stage IVA Cervical Cancer AJCC v6 and v7 | View |
| None | Stage IVB Cervical Cancer AJCC v6 and v7 | View |
Keywords: